![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07J 31/00 | |
A61K 31/56 | |||
A61P 5/44 |
(11) | Number of the document | 1472272 |
(13) | Kind of document | T |
(96) | European patent application number | 03704759.4 |
Date of filing the European patent application | 2003-02-04 | |
(97) | Date of publication of the European application | 2004-11-03 |
(45) | Date of publication and mention of the grant of the patent | 2010-03-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2003/000478 |
Date | 2003-02-04 |
(87) | Number | WO 2003/066656 |
Date | 2003-08-14 |
(30) | Number | Date | Country code |
67010 | 2002-02-04 | US |
(72) |
BIGGADIKE, Keith GlaxoSmithKline, GB
COOTE, Steven John c/o GlaxoSmithKline, GB
CRAIG, Andrew GlaxoSmithKline, GB
CROWE, David Malcolm GlaxoSmithKline, GB
JACEWICZ, Victor Witold c/o GlaxoSmithKline, GB
MILLAN, Michael John GlaxoSmithKline, GB
NICE, Rosalyn Kay c/o GlaxoSmithKline, GB
NOGA, Brian c/o GlaxoSmithKline, US
SEAGER, John Frederick c/o GlaxoSmithKline, GB
THEOPHILUS, Andrew Lewis GlaxoSmithKline, GB
|
(73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
(54) | CRYSTALLINE COMPLEXES OF FLUTICASONE 2-FUROATE |
CRYSTALLINE COMPLEXES OF FLUTICASONE 2-FUROATE |